Original Research

Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis

Kreckler L, Osinski M, Williams S, Whiting R

Journal of Experimental Pharmacology 2022, 14:43-57

Published Date: 9 February 2022